Glucuretic effects and renal safety of dapagliflozin in patients with type 2 diabetes | Semantic Scholar
A19-53 - Dapagliflozin - Nutzenbewertung gemäß § 35a SGB V - Version 1.0
Typ-2-Diabetes und Herz-Kreislauf-Risiko: Dapagliflozin hat positive Effekte auch in der kardiovaskulären Primärprävention
Sodium–glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy | Cardiovascular Diabetology | Full Text
forxiga® 10 mg Filmtabletten 98 St - shop-apotheke.com
Healthcare | Free Full-Text | Clinical Parameters Affecting the Therapeutic Efficacy of SGLT-2—Comparative Effectiveness and Safety of Dapagliflozin and Empagliflozin in Patients with Type 2 Diabetes
Forxiga (dapagliflozin) for Treatment of Type 2 Diabetes - Clinical Trials Arena
Dapagliflozin zur Therapie des Typ-2-Diabetes - 03 - 2013 - Heftarchiv - AMT
The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial -
Metformin und Dapagliflozin führen bei Typ 2 Diabetes zu ... - Evimed
Efficacy and safety of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: A meta‑analysis of randomized controlled trials
Incidence of new-onset type 2 diabetes mellitus (T2DM) in dapagliflozin... | Download Scientific Diagram
10 Jahre Dapagliflozin für Typ-2-Diabetes, HFrEF und CKD
Dapagliflozin zur Therapie des Typ-2-Diabetes - 03 - 2013 - Heftarchiv - AMT
Abstract 15581: Effect of Dapagliflozin on Atrial Fibrillation/Flutter in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial | Circulation
FDA erweitert Zulassung: Dapagliflozin künftig bei Herzinsuffizienz – auch ohne Diabetes
Typ-2-Diabetes | Einfluss von Dapagliflozin auf die endogene Glukoseproduktion bei Typ-2-Diabetes | springermedizin.de
Dapagliflozin Diabetes Drug molecule. Hemmer des Natrium-Glukose Transportproteine Subtyp 2 (sglt2). Der skelettmuskulatur Formel Stock-Vektorgrafik - Alamy
SGLT2-Inhibitoren zur Therapie des Typ-2-Diabetes
IJMS | Free Full-Text | Dapagliflozin Prevents NOX- and SGLT2-Dependent Oxidative Stress in Lens Cells Exposed to Fructose-Induced Diabetes Mellitus
Dapagliflozin May Reduce the Onset of Type 2 Diabetes - Beyond Type 2
Doppelwumms für Herz und Nieren
Dapagliflozin treatment for type 2 diabetes mellitus patients with a history of cardiovascular disease - Media Centre | EASD
